Actively Recruiting
ADHD&me: Targeting Self-esteem in Youth With ADHD
Led by Universiteit Leiden · Updated on 2026-05-14
110
Participants Needed
1
Research Sites
105 weeks
Total Duration
On this page
Sponsors
U
Universiteit Leiden
Lead Sponsor
L
Leids Universiteits Fonds
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn whether the ADHD\&me (ADHD\&ik) intervention can improve self-esteem in youth aged 16-25 years with Attention Deficit Hyperactivity Disorder (ADHD). The ADHD\&me program is a cognitive behavioral therapy (CBT)-based intervention designed to help people with ADHD to develop a more positive view of themselves in their transition to adulthood. The main questions it aims to answer are: * Does the ADHD\&me intervention improve self-esteem in youth with ADHD, and are these effects maintained over time? * Does the intervention also improve related outcomes, such as masking of ADHD-related behaviors and co-occurring mental health symptoms including anxiety, depression, and stress? In this RCT, participants are assigned either to immediate treatment or to a waitlist control condition, with the latter receiving the intervention after an eight-week delay. Participants will: * Take part in seven individual therapy sessions according to the ADHD\&me intervention. * Complete questionnaires about self-esteem, masking of ADHD-related behaviors, ADHD symptoms, and co-ccurring mental health symptoms at several time points. * Complete short daily assessments (ecological momentary assessment) during one week at the start of the study and one week after the intervention or waitlist period to report momentary self-esteem, emotions, distress, and activities.
CONDITIONS
Official Title
ADHD&me: Targeting Self-esteem in Youth With ADHD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 16 to 25 years
- Official ADHD diagnosis confirmed by a clinical interview (MINI-S)
- Low self-esteem indicated by clinician referral, specific screening questions, and baseline assessment including the Rosenberg Self-Esteem Scale (score < 15) combined with clinical interview
- Stable ADHD medication dose for at least 4 weeks prior to baseline (medication allowed)
You will not qualify if you...
- Severe mental health issues requiring immediate attention (e.g., severe depression, suicidal risk)
- Receiving any psychological treatment during the study, including ADHD therapy
- Low self-esteem primarily caused by trauma needing trauma-specific treatment
- IQ less than 80 measured by WAIS-IV subscales Vocabulary and Block Design
- Severe substance use
- Confirmed or highly suspected Autism Spectrum Disorder (ASD) diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Psychologenpraktijk Kuin
Haarlem, Netherlands
Actively Recruiting
Research Team
B
Bianca Boyer
CONTACT
J
Jasmin Rahemenia
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here